Definitive Contract 75N95024C00023
Award Date
9/24/24
Potential Completion Date
6/23/25
Potential Value
$325K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
On Demand Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Lynntech Inc., a small business. The contract is for the development of non-polydimethylsiloxane (PDMS) biocompatible alternatives for organs-on-chips, a topic under NCATS SBIR 2019 solicitation. The contract has a firm fixed-price of $225,000.00 and a completion date of January 31, 2020. Lynntech Inc. is a small business that...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
This federal contract award, identified as 75N95024P00330, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH). The contract, valued at $604,500.00, is for a subject matter expert consultant in medicinal chemistry to support the NIH Blueprint Neurotherapeutics Network (BPN) and BPN HEAL, Biologics programs. The award was made to NDC Medchem Consulting LLC, a small business, for a period of performance...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (DHHS), to Theranano LLC, a small disadvantaged, woman-owned business. The $300,000 fixed-price contract is for research on the sustained delivery of PARP inhibitors for cancer chemoprevention. This SBIR contract was issued under the DHHS/NIH/CDC SBIR Contract Solicitation PHS 2018-1, which sought proposals from small...
This is a $289,828.00 SBIR Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Nicolalde R&D LLC, a minority-owned, self-certified small disadvantaged business. The contract is a firm fixed-price definitive contract with a completion date of November 30, 2021. The SBIR (Small Business Innovation Research) Program Phase I award indicates this contract is for early-stage research and development activities. As a...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Synbal, Inc., a small business located in La Costa, California. The contract, valued at $2,300,000.00, is for the "Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics" under the "MOONSHOT" initiative. The contract was set aside for small businesses...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Program Phase I contract to B & W TEK Inc., a for-profit manufacturing organization, to develop new commercially viable devices, tools, technologies or integrated systems for drug detection and deactivation to deter opioid theft in hospitals. The definitive, firm fixed-price contract has a potential value of $224,656.02 and a...
This is a $1,746,809.01 definitive contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, to Collaborative Drug Discovery, Inc., a small business. The contract involves the development of a centralized information technology system for the NIH Blueprint Neurotherapeutics Network. The system is designed to collect, maintain, and analyze chemical structure and bioactivity data from multiple NIH-funded research projects,...
This is a base award to Scitech Strategies Inc., a small business, under the SBIR (Small Business Innovation Research) Program Phase I of the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The award is for the creation of an accurate model of the topical structure of PubMed and associated indicators. The contract has a firm fixed price of $225,000.00 for a period of performance from...